Article Text

Download PDFPDF
Oligometastatic renal cell carcinoma in the palatine tonsil: successful resection using trans-oral robotic surgery
  1. Talisa Ross1,2,
  2. Akshat Malik1 and
  3. Zaid Awad1,2
  1. 1Imperial College Healthcare NHS Trust, London, UK
  2. 2Imperial College London Faculty of Medicine, London, UK
  1. Correspondence to Ms Talisa Ross; talisaross{at}doctors.org.uk

Abstract

A man in his mid 70s was referred to head and neck outpatients with bulky tissue in the left tonsillar fossa. He had previously been treated for oligometastatic renal clear cell carcinoma (diagnosed over 15 years prior to disease recurrence) by tonsillectomy and adjuvant radiotherapy (years from primary treatment), followed by trans-oral laser surgery to his oropharyngeal recurrence 3 years later. Examination under anaesthetic and biopsy confirmed further recurrence of disease in the left tonsillar fossa, with parapharyngeal extension, which has not been previously reported in the literature. After discussion in the head and neck and urology multi-disciplinary teams meeting, the patient was offered trans-oral robotic-assisted surgery (TORS) for local control and prevention of progression of a fungating oropharyngeal mass. TORS partial pharyngectomy and left buccal artery myomucosal flap reconstruction were successfully carried out, with preservation of some swallow function.

  • head and neck cancer
  • head and neck surgery
  • otolaryngology / ENT

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @talisa_ross

  • Contributors TR wrote the article. AM edited manuscript and assisted with literature search. ZA provided concept for manuscript and edited manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not Required.

  • Provenance and peer review Not commissioned; externally peer reviewed.